News

CISCRP has shared a recent supplement on clinical trials in USA Today magazine.

Clinical trial data from completed trials are now beginning to be shared through a variety of channels. While skeptics remain, evidence is growing that this data can lead to practice-changing behavior in patient care.

DrugDev and Citeline, part of Informa’s Pharma Intelligence vertical, announced that data from Citeline’s Trialstrove and Sitetrove platforms have been integrated.

INC Research and inVentiv Health announced that their Boards of Directors have unanimously approved a merger agreement.

iCardiac announced that it has been selected to work on an early phase oncology clinical trial with a global Japanese pharma company.

Dr. George Atiee shares his perspectives, from that of the principal investigator, on how stakeholders can execute a successful study.

WIRB-Copernicus Group (WCG) has announced the acquisition of MedAvante and ProPhase, and has named Dr. Jeffrey Litwin as CEO of the combined organization.

The EU’s national health organizations are contemplating to abandon their highly-prized autonomy, and forge common positions and buying strategies for accessing expensive new drugs.

Transparency regarding the source of biospecimens would improve research quality, reproducibility, and translational use of acquired knowledge. Scientific robust publications, dissemination and communication are central to this-as are the regulatory reporting guidelines in play.

Medidata introduced the availability of its regulated content management platform (RCM), Medidata RCM.

NNIT announces that it has signed an extension of its infrastructure outsourcing agreement with Novo Nordisk.

eClinicalHealth Limited and Chilli Consultancy announce new streamlined clinical outcome assessment (COA) development services.

SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers.

Commonwealth Informatics announces the launch of a new product offering, Commonwealth Vigilance Workbench (CVW) Longitudinal.

In an open letter issued this week, the heads of research and development from several big pharma companies and the EFPIA have demanded a quick decision on the relocation of the EMA.

The EMA has unveiled a new survey to assess how its communication strategy to the general public is perceived and valued by its stakeholders.

George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division.